MONTHLY SUPPLY · ORAL TABLET
ANASTROZOLE
TREATMENT
Aromatase inhibitor for estrogen management during TRT
SUPPORTAnastrozole is a third-generation aromatase inhibitor that selectively blocks the conversion of androgens to estrogens. Used adjunctively in testosterone replacement therapy to prevent supraphysiological estradiol levels.
Shop NowLab-Tested · Physician-Supervised · Discreet Delivery
Apexion Health — HORMONE
KEEP ESTROGEN IN CHECK DURING TRT.
When exogenous testosterone is administered, a portion is aromatized into estradiol by the CYP19A1 aromatase enzyme in adipose, muscle, and other tissues. Excess estradiol during TRT produces symptoms including water retention, gynecomastia, mood instability, and reduced libido. Anastrozole competitively and selectively inhibits aromatase, reducing estrogen conversion without suppressing androgens — allowing your provider to fine-tune the testosterone-to-estradiol ratio to a physiological range.
Clinical Benefits
ANASTROZOLE SUPPORTS YOUR HEALTH AT THE CELLULAR LEVEL
- 01.
SELECTIVELY INHIBITS AROMATASE TO REDUCE ESTROGEN CONVERSION
- 02.
PREVENTS ESTRADIOL-RELATED SIDE EFFECTS DURING TRT
- 03.
REDUCES RISK OF GYNECOMASTIA AND WATER RETENTION
- 04.
SUPPORTS OPTIMAL TESTOSTERONE-TO-ESTRADIOL RATIO
- 05.
ORAL TABLET — CONVENIENT TWICE-WEEKLY DOSING
- 06.
PHYSICIAN-MONITORED WITH REGULAR HORMONE PANELS
Clinical Evidence